Lexaria Bioscience LEXX
NASDAQ LEXX
$2.82 +0.17 (+6.42%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Other Non-Current Liabilities (2020 - 2021)

Updated

Lexaria Bioscience's Other Non-Current Liabilities was $49,989 in fiscal Q4 2021 (quarter ended Aug 31, 2021), down 44.1% from $89,393 a year earlier.

Analysis

Lexaria Bioscience (LEXX) Other Non-Current Liabilities (2020 - 2021) Analysis & Trends

From fiscal Q4 2012 onward, Lexaria Bioscience has reported Other Non-Current Liabilities for 10 quarters.

  • In earlier fiscal years, Other Non-Current Liabilities was $89,393 in FY2020.
  • The fiscal Q4 2021 figure marks the lowest quarterly Other Non-Current Liabilities in data going back to fiscal Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Lexaria Bioscience 2.58 Mn -12.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2021 49,989.00
Aug 31, 2020 89,393.00
API Access

Lexaria Bioscience Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LEXX&period=max&api_key=YOUR_API_KEY